(Total Views: 519)
Posted On: 04/18/2021 9:35:52 PM
Post# of 145872
U.K MHRA asked for then open label data, Canada IO also would look at OLE data, certainly phillipines since we got the ball rolling over there with actually small CD-10 trial + EIND data. Now they have CD-12 and OLE and 29+ Filipino patients. Also Brazil is getting hammered they might not want to wait for new pvalue to prove it saves life’s, get severe criticals out of the hospital 6 days quicker than any drug currently approved.
Also I believe leronlimab is the very best ease of use Covid-19 therapeutic for Severe critical patients. One could receive a quick simple shot. I’ve stopped caring about FDA that is basically a guaranteed approval that will take several months. I am focusing my vision much like CYDY is on the more immediate short term possibilities of EUA and instant revenues in multiple other countries where covid is spiraling out of control.
Also I believe leronlimab is the very best ease of use Covid-19 therapeutic for Severe critical patients. One could receive a quick simple shot. I’ve stopped caring about FDA that is basically a guaranteed approval that will take several months. I am focusing my vision much like CYDY is on the more immediate short term possibilities of EUA and instant revenues in multiple other countries where covid is spiraling out of control.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)